Number of exacerbations during 12 month follow-up period | Total | |||||
---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | ≥4 | ||
n (%) | n (%) | n (%) | n (%) | n (%) | N | |
Overall | 481,822 (65.6) | 189,457 (25.8) | 43,592 (5.9) | 12,278 (1.7) | 6,965 (1.0) | 734,114 |
Gender | ||||||
Female | 205,789 (67.5) | 75,394 (24.7) | 16,517 (5.4) | 4,530 (1.5) | 2,635 (0.9) | 304,865 |
Male | 276,033 (64.3) | 114,063 (26.6) | 27,075 (6.3) | 7,748 (1.8) | 4,330 (1.0) | 429,249 |
Age groups | ||||||
0–1 years | 25,495 (55.5) | 14,078 (30.7) | 4,218 (9.2) | 1,359 (3.0) | 782 (1.7) | 45,932 |
> 1–2 years | 24,329 (54.6) | 14,176 (31.8) | 4,084 (9.2) | 1,282 (2.9) | 684 (1.5) | 44,555 |
> 2–3 years | 25,722 (57.0) | 13,904 (30.8) | 3,742 (8.3) | 1,138 (2.5) | 630 (1.4) | 45,136 |
4–12 years | 262,219 (66.3) | 101,711 (25.7) | 22,297 (5.6) | 6,077 (1.5) | 3,206 (0.8) | 395,510 |
13–17 years | 144,057 (71.0) | 45,588 (22.5) | 9,251 (4.6) | 2,422 (1.2) | 1,663 (0.8) | 202,981 |